BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
PRODID://CGC//520969
BEGIN:VEVENT
DTSTAMP:20260529T174027
VTIMEZONE:America/New_York
DTSTART:20260612T150000Z
DTEND:20260612T160000Z
UID:520969
SUMMARY:Accelerating Precision Oncology: Real-time genomic and epigenomic profiling with Oxford Nanopore
LOCATION:
DESCRIPTION:Accelerating Precision Oncology: Real-time genomic and epigenomic profiling with Oxford Nanopore\n\n06/12/26 11:00 AM EST\n - 06/12/26 12:00 PM EST\Description:\nThis webinar, sponsored by Oxford Nanopore Technologies, highlights how real-time Oxford Nanopore sequencing is transforming precision oncology through rapid genomic and epigenomic profiling. Dr. Parth S. Shah (Geisel School of Medicine at Dartmouth) will present his approach to accelerating the diagnosis and molecular characterization of hematologic malignancies using nanopore sequencing. Dr. Bastiaan Tops (Princess Maxima Center) will showcase a rapid, methylation-based classification workflow for CNS tumors.\n\nJoin us to hear how rapid molecular insights can be leveraged to inform clinical decision-making and advance time-critical cancer care.\n \nSpeakers: \nParth Shah, Director of Genome Informatics, Geisel School of Medicine at Dartmouth\nBastiaan B.J. Tops, Head of Laboratory of Childhood Cancer Pathology at Princess Máxima Center\n\n\n\n\nOxford Nanopore Technologies products are RUO. \nProducts labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. \nOxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.\n\n
X-ALT-DESC;FMTTYPE=text/html:Accelerating Precision Oncology: Real-time genomic and epigenomic profiling with Oxford Nanopore<br /><br />06/12/26 11:00 AM EST - 06/12/26 12:00 PM EST<br />Description:<br /><p><span style="font-family:tahoma,geneva,sans-serif"><span style="font-size:16px">This webinar,&nbsp;sponsored by Oxford Nanopore Technologies, highlights how real-time Oxford Nanopore sequencing is transforming precision oncology through rapid genomic and epigenomic profiling. Dr. Parth S. Shah (Geisel School of Medicine at Dartmouth) will present his approach to accelerating the diagnosis and molecular characterization of hematologic malignancies using nanopore sequencing. Dr. Bastiaan Tops (Princess Maxima Center) will showcase a rapid, methylation-based classification workflow for CNS tumors.<br />
<br />
Join us to hear how rapid molecular insights can be leveraged to inform clinical decision-making and advance time-critical cancer care.</span></span><br />
<span style="font-family:tahoma,geneva,sans-serif"><span style="font-size:16px">&nbsp;</span><br />
<span style="font-size:16px"><span style="color:#008080"><strong>Speakers:</strong></span>&nbsp;<br />
Parth Shah, Director of Genome Informatics, Geisel School of Medicine at Dartmouth<br />
Bastiaan B.J. Tops, Head of Laboratory of Childhood Cancer Pathology at&nbsp;Princess M&aacute;xima Center</span></span></p>

<div style="text-align: justify;">
<hr />
<div style="text-align: left;"><em><span style="font-size:14px"><span style="font-family:arial,helvetica,sans-serif"><img alt="" src="https://cancergenomics.org/photos/ONT_2Line_Black_RGB_10062025110702.JPG" style="width:200px" /></span></span><br />
<span style="font-size:12px"><span style="font-family:tahoma,geneva,sans-serif">Oxford Nanopore Technologies products are RUO.&nbsp;<br />
Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling.&nbsp;<br />
Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.</span></span></em></div>
</div>

PRIORITY:3
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-PT5M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR